FrancophonIA/ELRC3.0 huggingface dataset:
English: STATEMENT OF ACTIVE SUBSTANCE Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 0.5 mg anagrelide.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena trda kapsula vsebuje 0,5 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: How to take Anagrelide Mylan Always take Anagrelide Mylan exactly as your doctor has told you.
Slovenian: Pri jemanju zdravila Anagrelid Mylan natančno upoštevajte navodila zdravnika.
English: Anagrelide Mylan 1 mg hard capsules anagrelide
Slovenian: Anagrelid Mylan 1 mg trde kapsule anagrelid
English: STATEMENT OF ACTIVE SUBSTANCE Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 1 mg anagrelide.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena trda kapsula vsebuje 1 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: Anagrelide Mylan contains the active substance, anagrelide.
Slovenian: Zdravilo Anagrelid Mylan vsebuje učinkovino anagrelid.
English: Symptoms resolved with conservative management.
Slovenian: Simptomi prevelikega odmerjanja vključujejo sinusno tahikardijo in bruhanje, ki pa jih odpravimo s konservativnim zdravljenjem.
English: Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 0.5 mg anagrelide.
Slovenian: Ena trda kapsula vsebuje 0,5 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 1 mg anagrelide.
Slovenian: Ena trda kapsula vsebuje 1 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: NAME OF THE MEDICINAL PRODUCT Anagrelide Mylan 1 mg hard capsules anagrelide
Slovenian: IME ZDRAVILA Anagrelid Mylan 1 mg trde kapsule anagrelid
English: Dizziness has been reported by some patients taking anagrelide.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Pri nekaterih bolnikih, ki so jemali anagrelid, so poročali o omotici.
English: Atrial fibrillation Supraventricular tachycardia Arrhythmia Hypertension Syncope
Slovenian: Srčne bolezni tahikardija palpitacije ventrikularna tahikardija kongestivna srčna odpoved atrijska fibrilacija supraventrikularna tahikardija aritmija hipertenzija omedlevica miokardni infarkt kardiomiopatija kardiomegalija perikardni izliv angina pektoris posturalna hipotenzija vazodilatacija torsade de pointes
English: The potential risks and benefits of anagrelide therapy in a patient with mild impairment of hepatic function should be assessed before treatment is commenced (see sections 4.3 and 4.4).
Slovenian: Pred začetkom zdravljenja je treba ugotoviti morebitna tveganja in koristi pri zdravljenju z anagrelidom pri bolnikih z blagim do hudim poslabšanim delovanjem jeter (glejte poglavji 4.3 in
English: Each capsule contains anagrelide hydrochloride monohydrate equivalent to 0.5 mg anagrelide.
Slovenian: Ena kapsula vsebuje 0,5 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: Each capsule contains anagrelide hydrochloride monohydrate equivalent to 1 mg anagrelide.
Slovenian: Ena kapsula vsebuje 1 mg anagrelida v obliki anagrelidijevega klorida monohidrata.
English: The potential risks and benefits of anagrelide therapy in a patient with mild impairment of hepatic function should be assessed before treatment is commenced.
Slovenian: Pred začetkom zdravljenja je treba ugotoviti morebitna tveganja in koristi ob zdravljenju z anagrelidom pri bolnikih z blagim ali zmernim poslabšanjem delovanja jeter.
English: The NOEL (10 mg/kg/day) to this effect was 143, 12 and 11-fold higher than the AUC in humans administered a dose of anagrelide 2 mg/day, and the metabolites BCH24426 and RL603, respectively.
Slovenian: Pri odmerku, pri katerem ni več mogoče opaziti učinka (10 mg/kg/dan) so bile vrednosti AUC za anagrelid 143- krat večje, vrednosti AUC za presnovek BCH24426 12- krat večje in vrednosti AUC za presnovek RL603 11- krat večje kot pri ljudeh, ki so jim dajali peroralni odmerek 2 mg/dan.
English: especially in the skin, abnormal feeling or sensation such as tingling and ‘pins and needles', sleeplessness, depression, confusion, nervousness, dry mouth, loss of memory, breathlessness, nosebleed, serious lung infection with fever, shortness of breath, cough, phlegm; hair loss, skin itching or discolouration, impotence, chest pain, reduction in blood platelets, which increases the risk of bleeding or bruising (thrombocytopenia), accumulation of fluid around the lungs or an increase in liver enzymes.
Slovenian: Občasni neželeni učinki: pojavijo se lahko pri največ 1 od 100 bolnikov občutek šibkosti ali slabo počutje, visok krvni tlak, nereden srčni utrip, omedlevica, mrzlica ali povišana telesna temperatura, prebavne težave, izguba teka, zaprtje, modrice, krvavitve, otekanje (edem), izguba telesne mase, bolečine v mišicah, bolečine v sklepih, bolečine v križu, zmanjšanje ali izguba občutka ali zaznavanja, npr. odrevenelost, posebno v koži, nenormalen občutek ali zaznavanje, npr. zbadanje in mravljinčenje, nespečnost, depresija, zmedenost, nervoza, suha usta, izguba spomina, zasoplost, krvavenje iz nosa, resna okužba pljuč s povišano telesno temperaturo, kratko sapo, kašljem, gnojnim izkašljevanjem, izpadanje las, srbenje ali razbarvanje kože, impotenca (nezmožnost doseganja in vzdrževanja erekcije), bolečina v prsih, zmanjšanje koncentracije krvnih ploščic, ki zveča tveganje krvavitev ali podplutb (trombocitopenija), kopičenje tekočine okrog pljuč ali zvišanje jetrnih encimov.
English: Fluid retention Oedema Weight loss
Slovenian: Presnovne in prehranske motnje zastajanje tekočine edem izguba telesne mase pridobivanje telesne mase
English: Tubulointerstitial nephritis
Slovenian: Bolezni sečil impotenca ledvična odpoved nokturija tubulointersticijs ki nefritis
English: It works by increasing urine output, reducing the amount of fluid in the blood and lowering the blood pressure.
Slovenian: Deluje tako, da poveča izločanje seča, zaradi česar se zmanjša količina tekočine v krvi in zniža krvni tlak.
English: It is available as tablets (150 mg or 300 mg irbesartan and 12.5 mg hydrochlorothiazide; and 300 mg irbesartan and 25 mg hydrochlorothiazide).
Slovenian: Na voljo je v obliki tablet (150 mg ali 300 mg irbesartana in 12,5 mg hidroklorotiazida oziroma 300 mg irbesartana in 25 mg hidroklorotiazida).
English: The full EPAR for Irbesartan/Hydrochlorothiazide Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Irbesartan/Hydrochlorothiazide Teva je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: By lowering the blood pressure, the risks associated with high blood pressure, such as having a stroke, are reduced.
Slovenian: Z znižanjem krvnega tlaka se zmanjša možnost tveganj, povezanih z visokim krvnim tlakom, kot na primer možganska kap.
English: By blocking the receptors to which angiotensin II normally attaches, irbesartan stops the hormone having an effect, allowing the blood vessels to widen.
Slovenian: Irbesartan z zaviranjem receptorjev, na katere se angiotenzin II običajno veže, prepreči delovanje hormona, kar omogoči razširitev krvnih žil.
English: For more information about treatment with Irbesartan/Hydrochlorothiazide Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Irbesartan/Hydrochlorothiazide Teva preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: The combination of the two active substances has an additive effect, reducing the blood pressure more than either medicine alone.
Slovenian: Kombinacija obeh zdravilnih učinkovin daje pri zniževanju krvnega tlaka boljše rezultate kot vsaka učinkovina posamično.
English: The European Commission granted a marketing authorisation valid throughout the EU for Irbesartan/Hydrochlorothiazide Teva on 26 November 2009.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom IIrbesartan/Hydrochlorothiazide Teva, veljavno po vsej Evropski uniji, izdala 26. novembra 2009.
English: Hydrochlorothiazide is a diuretic, which is another type of treatment for hypertension.
Slovenian: Hidroklorotiazid je diuretik, kar je druga vrsta zdravila za zdravljenje hipertenzije.
English: Therefore, the CHMP's view was that, as for CoAprovel, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da koristi, tako kot pri zdravilu CoAprovel, odtehtajo znana tveganja.
English: Because Irbesartan/Hydrochlorothiazide Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Irbesartan/Hydrochlorothiazide Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: This is a summary of the European public assessment report (EPAR) for Irbesartan/Hydrochlorothiazide Teva.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Irbesartan/Hydrochlorothiazide Teva.
English: The CHMP concluded that, in accordance with EU requirements, Irbesartan/Hydrochlorothiazide Teva has been shown to have comparable quality and to be bioequivalent to CoAprovel.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Irbesartan/Hydrochlorothiazide Teva primerljivo raven kakovosti kot zdravilo CoAprovel ter da mu je biološko enakovredno.
English: This means that Irbesartan/Hydrochlorothiazide Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called CoAprovel.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu CoAprovel.
English: Irbesartan/Hydrochlorothiazide Teva is used in adults who have essential hypertension (high blood pressure) that is not adequately controlled by irbesartan or hydrochlorothiazide alone.
Slovenian: Zdravilo Irbesartan/Hydrochlorothiazide Teva se uporablja pri odraslih z esencialno hipertenzijo (visokim krvnim tlakom), ki ni ustrezno uravnana z uporabo samo irbesartana ali samo hidroklorotiazida.
English: Because Irbesartan/Hydrochlorothiazide Teva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, CoAprovel.
Slovenian: Ker je zdravilo Irbesartan/Hydrochlorothiazide Teva generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu CoAprovel.
English: Irbesartan/Hydrochlorothiazide Teva is a ‘generic medicine'.
Slovenian: Irbesartan/Hydrochlorothiazide Teva je „generično zdravilo“.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Irbesartan/Hydrochlorothiazide Teva.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil to zdravilo, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: The dose of Irbesartan/Hydrochlorothiazide Teva to be used depends on the dose of irbesartan or hydrochlorothiazide that the patient was taking
Slovenian: Odmerek zdravila Irbesartan/Hydrochlorothiazide Teva, ki naj ga bolnik uporabi, je odvisen od odmerka irbesartana ali hidroklorotiazida, ki ga je bolnik jemal pred tem.
English: Irbesartan/Hydrochlorothiazide Teva irbesartan and hydrochlorothiazide
Slovenian: Irbesartan/Hydrochlorothiazide Teva irbesartan in hidroklorotiazid
English: Other information about Irbesartan/Hydrochlorothiazide Teva
Slovenian: Druge informacije o zdravilu Irbesartan/Hydrochlorothiazide Teva
English: Irbesartan/Hydrochlorothiazide Teva may be added to other treatments for hypertension.
Slovenian: Zdravilo Irbesartan/Hydrochlorothiazide Teva se lahko uvede sočasno z drugimi načini zdravljenja hipertenzije.
English: What are the benefits and risks of Irbesartan/Hydrochlorothiazide Teva?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Irbesartan/Hydrochlorothiazide Teva?
English: The Committee recommended that Irbesartan/Hydrochlorothiazide Teva be given marketing authorisation.
Slovenian: Priporočil je, da se za zdravilo Irbesartan/Hydrochlorothiazide Teva izda dovoljenje za promet.
English: Irbesartan/Hydrochlorothiazide Teva is a medicine that contains two active substances, irbesartan and hydrochlorothiazide.
Slovenian: Irbesartan Hydrochlorothiazide Teva je zdravilo, ki vsebuje dve zdravilni učinkovini, irbesartan in hidroklorotiazid.
English: Irbesartan/Hydrochlorothiazide Teva contains two active substances, irbesartan and hydrochlorothiazide.
Slovenian: Zdravilo Irbesartan/Hydrochlorothiazide Teva vsebuje dve zdravilni učinkovini, irbesartan in hidroklorotiazid.
English: Why has Irbesartan/Hydrochlorothiazide Teva been approved?
Slovenian: Zakaj je bilo zdravilo Irbesartan/Hydrochlorothiazide Teva odobreno?
English: How has Irbesartan/Hydrochlorothiazide Teva been studied?
Slovenian: Kako je bilo zdravilo Irbesartan/Hydrochlorothiazide Teva raziskano?
English: What is Irbesartan/Hydrochlorothiazide Teva?
Slovenian: Kaj je zdravilo Irbesartan/Hydrochlorothiazide Teva?
English: How is Irbesartan/Hydrochlorothiazide Teva used?
Slovenian: Kako se zdravilo Irbesartan/Hydrochlorothiazide Teva uporablja?
English: What is Irbesartan/Hydrochlorothiazide Teva used for?
Slovenian: Za kaj se zdravilo Irbesartan/Hydrochlorothiazide Teva uporablja?
English: How does Irbesartan/Hydrochlorothiazide Teva work?
Slovenian: Kako zdravilo Irbesartan/Hydrochlorothiazide Teva deluje?
English: Irbesartan/Hydrochlorothiazide Teva is taken by mouth.
Slovenian: Zdravo Irbesartan/Hydrochlorothiazide Teva se jemlje peroralno.
English: Your doctor will do regular blood tests to check for any changes in:
Slovenian: Vaš zdravnik bo izvajal redne preiskave krvi, da bo preverjal spremembe v:
English: Date of latest renewal: 13 March 2006
Slovenian: Datum zadnjega podaljšanja: 13. marec 2006
English: Step 2 a.
Slovenian: Korak 2 a.
English: Children (aged 2 to 18 years)
Slovenian: Otroci (stari od 2 do 18 let)
English: Allow it to dry in the air before using it again.
Slovenian: Pustite, da se posuši na zraku, preden ga boste naslednjič uporabljali.
English: Your treatment will then continue at the normal times.
Slovenian: Vaše zdravljenje se bo nadaljevalo po normalnem urniku.
English: There are limited safety and efficacy data in children below the age of 2 years.
Slovenian: O varnosti in učinkovitosti pri otrocih, mlajših od dveh let, je na voljo premalo podatkov.
English: Your baby may be affected by one or more of these.
Slovenian: Vašega otroka bi lahko prizadela ena ali več od navedenih nepravilnosti.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 14 February 1996
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve odobritve: 14. februar 1996
English: Add the rest of the water.
Slovenian: Dodajte preostalo količino vode.
English: Your doctor or nurse will make up the medicine and give it to you.
Slovenian: Zdravnik ali medicinska sestra bosta pripravila zdravilo in vam ga dala.
English: Cellcept is usually given by a doctor or nurse in hospital.
Slovenian: Zdravilo CellCept ponavadi daje zdravnik ali medicinska sestra v bolnišnici.
English: Your doctor will have to advise you on which vaccines you can have.
Slovenian: Vaš zdravnik vam bo svetoval, katera cepiva lahko prejmete.
English: You will have the medicine for at least 4 days.
Slovenian: • Zdravilo boste prejemali vsaj 4 dni.
English: The educational materials shall contain the following key elements:
Slovenian: Izobraževalna gradiva naj vsebujejo naslednje ključne elemente:
English: Do not take a double dose to make up for a missed dose.
Slovenian: Ne vzemite dvojnega odmerka, da bi nadomestili pozabljeni odmerek.
English: If you are planning to have a child, talk to your doctor about the potential risks and alternative therapies.
Slovenian: Če nameravate imeti otroka, se pogovorite z zdravnikom o možnih tveganjih in drugih možnih zdravljenjih.
English: • Your ovaries no longer work (premature ovarian failure, which has been confirmed by a specialist gynaecologist)
Slovenian: • vaši jajčniki ne delujejo več (prezgodnja okvara jajčnikov, ki jo je potrdil specialist ginekolog);
English: Talk to your doctor about the most suitable contraception for you.
Slovenian: Z zdravnikom se pogovorite o izbiri kontracepcije, ki je za vas najbolj primerna.
English: taken twice a day.
Slovenian: 2 g na dan.
English: It is available in packs of 4 vials.
Slovenian: • Na voljo je v pakiranju po 4 viale.
English: Turn the whole thing upside down (bottle and dispenser - see picture below).
Slovenian: Oboje skupaj obrnite na glavo (steklenico in razdelilnik - glejte spodnjo sliko).
English: This includes medicines obtained without a prescription, such as herbal medicines.
Slovenian: To vključuje zdravila, ki ste jih dobili brez recepta, kot so rastlinski pripravki.
English: This will be given as 1 g in the morning and then 1 g in the evening.
Slovenian: • Dobili boste 1 g zjutraj in 1 g zvečer.
English: If you feel drowsy, numb or confused, talk to your doctor or nurse and do not drive or use any tools or machines until you feel better.
Slovenian: Če ste zaspani, omotični ali zmedeni, se pogovorite z zdravnikom ali medicinsko sestro; ne vozite in ne uporabljate nobenega orodja ali strojev, dokler se ne počutite bolje.
English: If you need to do it yourself, see Section 7 “Making up the medicine”
Slovenian: Če ga morate pripraviti sami, glejte poglavje 7 »Priprava zdravila«.
English: You are a woman who is not capable of becoming pregnant if any of the following applies to you:
Slovenian: Med ženske, ki ne morejo zanositi, sodite, če kar koli izmed naslednjega velja za vas:
English: • Immediately after use - take the dispenser to pieces and rinse it under running tap water.
Slovenian: • Takoj po uporabi - razdelilnik razstavite in ga sperite pod tekočo vodo.
English: • You are a child or teenager who has not started having periods.
Slovenian: • ste otrok ali najstnica, ki še ni dobila prve menstruacije.
English: Do not use the suspension past this expiry date.
Slovenian: Po tem datumu suspenzije ne uporabljajte.
English: They will follow the instructions under Section 7 “Making up the medicine”.
Slovenian: Sledila bosta navodilom, ki so zapisana v poglavju 7 »Priprava zdravila«.
English: In addition, there have been isolated reports of the following malformations:
Slovenian: Dodatno so zabeležili posamezna poročila o naslednjih malformacijah:
English: Pull the plunger out slowly.
Slovenian: Počasi izvlecite bat.
English: Swallow your tablets whole with a glass of water.
Slovenian: • Pogoltnite cele tablete s kozarcem vode.
English: There have also been reports of bronchiectasis in children and adults.
Slovenian: Poročali so o primerih bronhiektazije pri otrocih in odraslih.
English: Preparation of suspension
Slovenian: Priprava suspenzije:
English: The amount you take depends on the type of transplant you have had.
Slovenian: Količina, ki jo vzamete, je odvisna od tipa presadka, ki ga imate.
English: the number of your blood cells or signs of infections.
Slovenian: • številu krvnih celic ali znake okužb.
English: Put the end of the dispenser directly into your mouth and swallow the medicine.
Slovenian: Konec razdelilnika dajte neposredno v usta in pogoltnite zdravilo.
English: The bottle adapter should stay in the bottle.
Slovenian: Nastavek za steklenico mora ostati na steklenici.
English: • pneumonia, bronchitis,
Slovenian: • pljučnica, bronhitis,
English: Patients in all study arms also received cyclosporine and corticosteroids.
Slovenian: Bolniki v vseh študijskih skupinah so prejemali tudi ciklosporin in kortikosteroide.
English: This needs mixing with glucose before using.
Slovenian: Pred uporabo se mora zmešati z glukozo.
English: (50 tablets)
Slovenian: (50 tablet)
English: Additional risk minimisation measures
Slovenian: • Dodatni ukrepi za zmanjševanje tveganj
English: • telmisartan - used to treat high blood pressure
Slovenian: • telmisartan - uporablja se za zdravljenje visokega krvnega tlaka.
English: • rifampicin - an antibiotic used to prevent and treat infections such as tuberculosis (TB)
Slovenian: • rifampicin - antibiotik, ki se uporablja za preprečevanje in zdravljenje okužb, kot je tuberkuloza,
English: Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Slovenian: Pred začetkom uporabe natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
English: You may get general side effects affecting your body as a whole.
Slovenian: Pojavijo se lahko splošni neželeni učinki, ki se nanašajo na telo kot celoto.
English: • antibiotics - used to treat bacterial infections
Slovenian: • antibiotiki - uporabljajo se za zdravljenje bakterijskih okužb,
English: It is given as a slow drip (infusion) into a vein.
Slovenian: Daje se kot počasna infuzija v žilo.
English: It is recommended, however, to administer CellCept at least one hour before or three hours after sevelamer intake to minimise the impact on the absorption of MPA.
Slovenian: Vseeno je priporočljivo, da dajemo zdravilo CellCept vsaj eno uro pred ali tri ure po dajanju sevelamerja, zato da zmanjšamo vpliv na absorpcijo mikofenolne kisline.
English: In this leaflet the shorter name CellCept is used.
Slovenian: • V tem navodilu se uporablja skrajšano ime CellCept.
English: Also other medicines can affect the way CellCept works.
Slovenian: Prav tako lahko druga zdravila vplivajo na delovanje zdravila CellCept.
English: Component of a multipack, can't be sold separately.
Slovenian: Sestavnih delov skupnega pakiranja ni mogoče prodajati posebej.
English: This needs mixing with purified water before using.
Slovenian: Pred uporabo ga je treba zmešati s prečiščeno vodo.
English: If you do not fully understand these instructions, please ask your doctor to explain them again before you take mycophenolate.
Slovenian: Če teh navodil ne boste popolnoma razumeli, se posvetujte z zdravnikom, da vam jih bo ponovno razložil, preden boste vzeli mofetilmikofenolat.
English: However, at high MPAG plasma concentrations (> 100µg/mL), small amounts of MPAG are removed.
Slovenian: Pri visokih koncentracijah mikofenolglukuronida v plazmi (> 100 μg/ml) se majhne količine mikofenolglukuronida vendarle odstranijo.
English: Like all medicines, CellCept can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila lahko tudi zdravilo CellCept povzroča neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: Cellcept may cause somnolence, confusion, dizziness, tremor or hypotension, and therefore patients are advised to use caution when driving or using machines.
Slovenian: Zdravilo CellCept lahko povzroči zaspanost, zmedenost, omotico, tremor ali hipotenzijo, zato bolnikom priporočamo previdnost pri vožnji ali upravljanju strojev.
English: Paediatric population aged 2 to 18 years
Slovenian: Pediatrični bolniki, stari od 2 do 18 let
English: Also try not to get it on your skin, inside your mouth or nose.
Slovenian: Prav tako pazite, da ne zaide na vašo kožo, v usta ali nos.